ZAZOVE ASSOCIATES LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
ZAZOVE ASSOCIATES LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$1,185,000
-29.1%
85,7240.0%0.11%
-23.1%
Q1 2022$1,672,000
-57.3%
85,724
-39.0%
0.15%
-57.0%
Q3 2021$3,912,000
+152.7%
140,430
+168.8%
0.34%
+146.0%
Q2 2021$1,548,000
+6.0%
52,2350.0%0.14%
-19.2%
Q1 2021$1,460,000
+715.6%
52,235
+725.5%
0.17%
+681.8%
Q4 2020$179,0006,3280.02%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$42,779,00061.17%
Essex Woodlands Management, Inc. 3,342,047$91,739,00021.30%
Sio Capital Management, LLC 101,292$2,780,0001.54%
Fosun International Ltd 472,532$12,971,0000.66%
Rhenman & Partners Asset Management AB 203,181$5,577,0000.57%
ArrowMark Colorado Holdings LLC 1,804,275$49,527,0000.46%
ESSEX INVESTMENT MANAGEMENT CO LLC 87,355$2,398,0000.30%
FOX RUN MANAGEMENT, L.L.C. 18,477$507,0000.16%
Phoenix Investment Adviser LLC 2,400$66,0000.12%
Quinn Opportunity Partners LLC 33,100$909,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders